ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

DeVita Reshuffling NCI Office Space

April 18, 1980

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

In Congress: Clinton Backs Genetic Privacy Bills, But Plans Changes Proposals

July 18, 1997

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

July 6, 2012